Abstract
We present a timely evaluation of the impact of lockdown on the 2019-nCov epidemic in Hubei province, China. The implementation appears to be effective in reducing about 60% of new infections and deaths, and its effect also appears to be sustainable even after its removal. Delaying its implementation reduces its effectiveness. However, the direct economic cost of such a lockdown remains to be seen and whether the model is replicable in other Chinese regions remains a matter of further investigation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Natural Science Foundation of China (grant numbers: 8191101420(LZ), 11801435 (MS), 11631012 (YX), 81673275(ZP), 91846302(ZP)); Thousand Talents Plan Professorship for Young Scholars (grant number 3111500001); Xi’An Jiaotong University Young Talent Support Program; China Postdoctoral Science Foundation (grant number 2018M631134); the Fundamental Research Funds for the Central Universities (grant number xjh012019055); Natural Science Basic Research Program of Shaanxi Province (Grant number: 2019JQ-187); the National S&T Major Project Foundation of China (2018ZX10715002-004, 2018ZX10713001-001) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). YG was supported by Career Development Fellowships of the Australian National Health and Medical Research Council (numbers APP1107107 and APP1163693 ).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data was attached in the Appendix.
